Current Understanding of Moyamoya Disease (MMD) and Associated Neuropsychiatric Outcomes.

Authors:
Antonov A; Terraciano A; Essibayi MA; Javed K; Altschul DJ.

Journal:
Neuropsychiatr Dis Treat

Publication Year: 2023

DOI:
10.2147/NDT.S402375

PMCID:
PMC10710948

PMID:
38090021

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Neuropsychiatr Dis Treat

Abbreviation: Neuropsychiatr Dis Treat

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Psychiatry

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
4-Hydroxysesamin, a Modified Natural Compound, Attenuates Neuronal Apoptosis After Ischemic Stroke …
Wang L; Qu Z; Sun Q and 3 more (2024) - Transparency Score: 3/6
A Cross-Sectional Survey on Psychological Health and Influencing Factors Among 2628 Asymptomatic an…
Zhao M; Liu FX; Wang XL and 2 more (2024) - Transparency Score: 3/6
A Thematic Analysis Investigating the Inaugural Psychosis REACH Family Ambassador Peer Training Pro…
Vaswani-Bye A; McCain C; Blank JM and 2 more (2024) - Transparency Score: 3/6
Biological Markers in Newly Diagnosed Generalized Anxiety Disorder Patients: 8-OHdG, S100B and Oxid…
Oktay M; Asoğlu M; Taskin S and 1 more (2024) - Transparency Score: 3/6
Characteristics of Oral-Gut Microbiota in Model Rats with CUMS-Induced Depression.
Li Y; Liu P. (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure Dr David Altschul is a consultant for Microvention, Stryker, and Cerenovus. The authors report no other conflicts of interest in this work."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025